[EN] INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHODS OF THEIR USE<br/>[FR] INHIBITEURS DE TYROSINE KINASE DE BRUTON ET LEURS PROCÉDÉS D'UTILISATION
申请人:JANSSEN PHARMACEUTICA NV
公开号:WO2018103058A1
公开(公告)日:2018-06-14
Compounds of formula (I') and methods of their use and preparation, as well as compositions comprising compounds of formula (I').
公式(I')的化合物及其使用和制备方法,以及包含公式(I')化合物的组合物。
Developing Pd(II) Catalyzed Double sp<sup>3</sup> C–H Alkoxylation for Synthesis of Symmetric and Unsymmetric Acetals
作者:Yu Zong、Yu Rao
DOI:10.1021/ol502377x
日期:2014.10.17
effective Pd(II) catalyzed double unactivated C(sp3)–H alkoxylation has been developed to prepare both symmetric and unsymmetric acetals. This new reaction demonstrates good functional group tolerance, excellent reactivity, and high yields. A variety of novel acetals can be readily accessed via this newmethod.
Efficient copper-catalyzed Michael addition of acrylic derivatives with primary alcohols in the presence of base
作者:Feng Wang、Haijun Yang、Hua Fu、Zhichao Pei
DOI:10.1039/c2cc37595h
日期:——
A novel and efficient copper-catalyzed Michael addition of acrylic derivatives with primary alcohols in the presence of base has been developed. The protocol uses readily available acrylic derivatives and primary alcohols as the starting materials, inexpensive CuCl2 as the catalyst, and the corresponding addition products were obtained in moderate to excellent yields.
The present invention is concerned with novel dual modulators of the 5-HT
2A
and D
3
receptors of formula (I)
wherein X, Y, A, R
1
, R
2
, and R
3
are as described herein, as well as pharmaceutically acceptable salts and esters thereof. Further the present invention is concerned with the manufacture of the compounds of formula (I), pharmaceutical compositions comprising them and their use as therapeutics.
The present invention is concerned with novel dual modulators of the 5-HT
2A
and D
3
receptors of formula (I)
wherein X, Y, A, R
1
, R
2
, and R
3
are as described herein, as well as pharmaceutically acceptable salts and esters thereof. Further the present invention is concerned with the manufacture of the compounds of formula (I), pharmaceutical compositions comprising them and their use as therapeutics.